These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Elementary pharmacokinetics in clinical practice 2: Basic concepts of drug pharmacokinetics. Paxton JW N Z Med J; 1981 Nov; 94(695):342-5. PubMed ID: 6950264 [No Abstract] [Full Text] [Related]
23. [Some fundamental concepts of pharmacokinetic practice]. Perrier CV; Griessen M Pharm Acta Helv; 1974; 49(7-8):217-28. PubMed ID: 4462123 [No Abstract] [Full Text] [Related]
24. Studies on absorption and elimination of drugs. Ksiezyk M; Danek A Int J Clin Pharmacol; 1973 Nov; 8(3):222-7. PubMed ID: 4272488 [No Abstract] [Full Text] [Related]
25. [Pharmacokinetics and compartmental analysis]. Grégoire F J Pharm Belg; 1972; 27(1):98-110. PubMed ID: 5017459 [No Abstract] [Full Text] [Related]
26. An overview of the analysis and interpretation of bioavailability studies in man. Wagner JG Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190 [TBL] [Abstract][Full Text] [Related]
29. Significance of error associated with use of the one-compartment formula to calculate clearance of thirty-eight drugs. Dvorchik BH; Vessell ES Clin Pharmacol Ther; 1978 Jun; 23(6):617-23. PubMed ID: 648075 [No Abstract] [Full Text] [Related]
31. A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory. Chan KK Drug Metab Dispos; 1982; 10(5):474-9. PubMed ID: 6183086 [TBL] [Abstract][Full Text] [Related]
32. [Procedure for fitting pharmacokinetic data: a comparison of programs and the importance of the weight of the data]. Testa R; Vanasia A; Bertin D Farmaco Prat; 1984 Jun; 39(6):199-210. PubMed ID: 6547682 [No Abstract] [Full Text] [Related]
33. Evaluation of drug absorption by nonlinear regression, statistical moments, and Loo-Riegelman methods. Patel IH; Bornemann L; Colburn WA J Pharm Sci; 1985 Mar; 74(3):359-60. PubMed ID: 4009451 [No Abstract] [Full Text] [Related]
34. Clearance and biologic half-life as indices of intrinsic hepatic metabolism. Perrier D; Gibaldi M J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599 [No Abstract] [Full Text] [Related]
35. [Drug distribution in the body. I. Estimation of the kinetic rate and quantitation by statistical moments]. LeBlanc PP; LeBel M J Pharm Belg; 1986; 41(2):69-74. PubMed ID: 3735052 [No Abstract] [Full Text] [Related]
36. Influence of complex formation on drug transport. Vaidhyanathan VS J Pharm Sci; 1972 Jun; 61(6):894-900. PubMed ID: 5046105 [No Abstract] [Full Text] [Related]
37. Calculation of kinetic constants for an open two-compartmental model from drug excretion data. Janků I; Krebs V Eur J Pharmacol; 1971 May; 14(3):286-90. PubMed ID: 5156147 [No Abstract] [Full Text] [Related]
38. [Use of compartment models in the pharmacokinetics]. Weiss M; Förster W Z Gesamte Inn Med; 1976 Sep; 31(17):673-9. PubMed ID: 997662 [TBL] [Abstract][Full Text] [Related]
39. Determination of drug action. Mather LE Anaesth Intensive Care; 1980 Aug; 8(3):233-47. PubMed ID: 7425274 [No Abstract] [Full Text] [Related]
40. Relevance, experiences, and trends in the use of compartmental models. Segre G Drug Metab Rev; 1984; 15(1-2):7-53. PubMed ID: 6378563 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]